Synterica, Inc. Email Format
Biotechnology ResearchMaryland, United States1 Employees
Synterica, Inc. is a biotechnology research company focused on developing oral therapeutics aimed at treating enteric diseases and supporting gastrointestinal health. Its work centers on directly targeting pathogenic bacteria and their toxins in the gut while preserving beneficial microflora, addressing concerns associated with antibiotic resistance and disruption of gut balance. The first product focus is an oral therapeutic intended to neutralize toxins produced by Clostridium difficile, with the goal of reducing disease pathogenesis. The company is based in Baltimore, Maryland, and operates in a research-intensive segment of the biotechnology sector. While currently small in size, Synterica pursues innovations that combine targeting and neutralization strategies with a natural delivery framework sourced from living ingestible organisms, intended for scalable production.